Report Highlights
Australia and New Zealand Radiotherapy Market Size And Forecast
According to Verified Market Research, the Australia Radiotherapy Market was valued at USD 547.3 Million in 2018 and is projected to reach USD 950.8 Million by 2026, growing at a CAGR of 7.34% from 2019 to 2026. However, the New Zealand Radiotherapy Market was valued at USD 73.2 Million in 2018 and is projected to reach USD 129.0 Million by 2026, growing at a CAGR of 7.48% from 2019 to 2026.
Australia and New Zealand Radiotherapy Market Outlook
A few of the major factors driving the growth of the Radiotherapy market in Australia and New Zealand are the growing number of cancer patients, increasing adoption of radiotherapy devices and procedures, increasing the geriatric population and technological advancements in radiotherapy devices. However, the lack of skilled professionals for radiotherapy may hinder market growth.
Australia and New Zealand Radiotherapy Market, Segment Analysis
Australia and New Zealand Radiotherapy Market are segmented on the basis of End-User, Component, Type, and Country.
Australia and New Zealand Radiotherapy Market, Competitive Landscape
The Australia & New Zealand Radiotherapy Market is highly fragmented with the presence of a large number of players. Some of the major companies Genesis, NL-TEC Pty Ltd, Alphatech Systems Limited, Varian, Elekta, Sirtex, Noxopharm, Philips, Telix Pharmaceutical and Theranostics Australia.
Varian is one of the top five players for the Australia and New Zealand Radiotherapy market.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More